Farmacevtski vestnik – posebna izdaja – Joint Meeting on Medicinal Chemistry, junij 2007

  • New antimicrobial agents: Why we need them and what molecular targets should we choose?
  • Oncogenic JAK/STAT signalling pathways: Modelling of inhibitors and simulation studies
  • CDK inhibitors as novel antitumor therapeutics
  • De novo molecular design: A powerful strategy for the discovery of new potential antimalarials
  • Novel aldose reductase acetic acid inhibitors bearing a five membered heterocyclic core
  • Phosphinic and phosphonic peptides – novel inhibitors of urease
  • Spletna lekarna v Sloveniji
  • Synthesis of quinazolinocarboline alkaloid analogues
  • Searching for new CB1 antagonists, analogues of rimonabant
  • The Synthesis of deuterated tolperisone and tolperisone metabolites
  • Synthesis and cytotoxicity of di(8-quinolyl)disulfides
  • New 2-aminoethanol derivatives as orally active antiestrogenic agents
  • Multiple ligands applied to dopamine and adenosine receptors